retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial for weight loss: Study shows 30% body weight loss Lilly's triple agonist achieves 16.8%
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14


























